Skip to Content

Medacta Group SA Ordinary Shares MOVE

Morningstar Rating
CHF 122.00 +1.40 (1.16%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MOVE is trading within a range we consider fairly valued.
Price
CHF 121.06
Fair Value
CHF 643.58
Uncertainty
High
1-Star Price
CHF 714.82
5-Star Price
CHF 12.18
Economic Moat
Vbtdh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MOVE is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 120.60
Day Range
CHF 120.60122.20
52-Week Range
CHF 98.10135.00
Bid/Ask
CHF 120.80 / CHF 0.00
Market Cap
CHF 2.43 Bil
Volume/Avg
13,401 / 9,954

Key Statistics

Price/Earnings (Normalized)
45.72
Price/Sales
4.85
Dividend Yield (Trailing)
0.45%
Dividend Yield (Forward)
0.45%
Total Yield
0.61%

Company Profile

Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
1,730

Comparables

Valuation

Metric
MOVE
VBSN
MED
Price/Earnings (Normalized)
45.7220.821,143.70
Price/Book Value
7.842.113.78
Price/Sales
4.852.164.49
Price/Cash Flow
21.4316.0257.64
Price/Earnings
MOVE
VBSN
MED

Financial Strength

Metric
MOVE
VBSN
MED
Quick Ratio
0.823.891.56
Current Ratio
2.334.423.08
Interest Coverage
9.58887.052.76
Quick Ratio
MOVE
VBSN
MED

Profitability

Metric
MOVE
VBSN
MED
Return on Assets (Normalized)
8.23%8.59%0.62%
Return on Equity (Normalized)
17.55%10.63%0.84%
Return on Invested Capital (Normalized)
13.31%9.97%0.92%
Return on Assets
MOVE
VBSN
MED
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHgpffrqsRmdvs$182.3 Bil
SYK
Stryker CorpLxyhfvqbtTwh$126.5 Bil
MDT
Medtronic PLCKymncwzjhPwzdhk$111.9 Bil
BSX
Boston Scientific CorpWgpgyktRnypj$108.0 Bil
EW
Edwards Lifesciences CorpWfbcyctntxMzyfsz$54.3 Bil
DXCM
DexCom IncSkcbbylsWgm$49.5 Bil
PHG
Koninklijke Philips NV ADRYdjbslfbFlpckgn$25.6 Bil
ZBH
Zimmer Biomet Holdings IncFlskddbbmGvlt$24.7 Bil
ALGN
Align Technology IncJpsxgqdhqWwrpvbp$21.1 Bil
PODD
Insulet CorpVhvdhklrjDjnkjsv$11.3 Bil

Sponsor Center